Cart
sales@molnova.com
Oxyphencyclimine Hydrochloride
CAS No. 125-52-0
Oxyphencyclimine Hydrochloride( —— )
Catalog No. M17223 CAS No. 125-52-0
Oxyphencyclimine Hydrochloride is a synthetic tertiary amine and antimuscarinic agent with antispasmodic and antisecretory activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 61 | In Stock |
|
| 5MG | 82 | In Stock |
|
| 10MG | 142 | In Stock |
|
| 25MG | 268 | In Stock |
|
| 50MG | 401 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOxyphencyclimine Hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxyphencyclimine Hydrochloride is a synthetic tertiary amine and antimuscarinic agent with antispasmodic and antisecretory activities.
-
DescriptionOxyphencyclimine Hydrochloride is a synthetic tertiary amine and antimuscarinic agent with antispasmodic and antisecretory activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorMuscarinic AChR
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number125-52-0
-
Formula Weight380.91
-
Molecular FormulaC20H29ClN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc(c(cc1CNC[C@@H](c1c2ccc(=O)[nH]c2c(cc1)O)O)Cl)NC(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Waelbroeck M, et al. Eur J Pharmacol. 1992 Sep 1;227(1):33-42.
molnova catalog
related products
-
GNE-064
GNE-064 is a selective, orally active and highly soluble inhibitor of SMARCA4, SMARCA2 and PBRM1 bromodomains 5.
-
CPI-0610 carboxylic ...
CPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protein.
-
FHT-1015
FHT-1015 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with potential anticancer activity for the study of cancer and inflammation.
